The mucosal immune microenvironment in chronic pharyngitis: epithelial barrier dysfunction, inflammatory persistence, and therapeutic perspectives
- 1Department of Pharmacy, China-Japan Union Hospital of Jilin University
- 2School of Pharmaceutical Sciences, Jilin University
Abstract
Chronic pharyngitis is a clinically heterogeneous condition in which persistent throat symptoms, visible mucosal abnormalities, and underlying biological processes do not necessarily coincide. This critical narrative review synthesizes evidence from human chronic pharyngitis, experimental injury models, adjacent upper-airway disorders, and other mucosal systems to examine how epithelial barrier function, innate and adaptive immunity, microbial ecology, sensory signaling, and tissue repair may contribute to disease persistence. Experimental studies identify epithelial injury and activation of shared inflammatory and stress-response pathways, while human observations highlight substantial variation in anatomical site, microbial findings, immune organization, and treatment response. Adaptive immune responses appear strongly context dependent; microbial community changes are most informative when linked to organism viability, metabolite production, host sensing, or colonization resistance; and sensory pathways may contribute to symptoms partly independently of measurable inflammation. We propose that persistent disease can arise through three overlapping routes: continued exposure, durable alteration of tissue responsiveness, and incomplete resolution or repair, with microbial and sensory processes acting as modifiers. This framework separates symptom improvement, biological target engagement, and durable restoration of tissue function as distinct therapeutic outcomes. Future studies should prioritize anatomically precise longitudinal cohorts, site-resolved single-cell and spatial profiling, functional perturbation in primary pharyngeal systems, and mechanism-informed trials with follow-up after treatment withdrawal. By linking clinical presentation to local biological function and recovery trajectories, chronic pharyngitis may be reclassified into reproducible biological subgroups that support more precise mechanistic investigation and treatment.
Related
- Mitochondrial quality control and intestinal barrier dysfunction in inflammatory bowel disease: knowledge mapping and translational perspectives on traditional Chinese medicine-derived bioactive compounds
- The pleural tuberculosis–associated microenvironment promotes HIV-1 persistence by impairing CD8+ T cell–mediated viral control
- MSC-derived extracellular vesicles for spinal cord injury: inflammatory microenvironment modulation, stage-dependent repair mechanisms, and translational challenges
- MULTI-COHORT TRANSCRIPTOMIC ANALYSIS REVEALS SHARED INFLAMMATORY SIGNALING AND UROTHELIAL DYSFUNCTION ACROSS IC/BPS PHENOTYPES
- Circadian orchestration of the cutaneous microenvironment and chronotherapeutic strategies in inflammatory skin diseases
BibTeX
@article{sun2026mucosal,
title = {{The mucosal immune microenvironment in chronic pharyngitis: epithelial barrier dysfunction, inflammatory persistence, and therapeutic perspectives}},
author = {Yao Sun and Zetong Hong and Yiming Guo and Haizhen Cui and Yueyao Jiang and Qian Yu},
journal = {Frontiers in Immunology},
year = {2026},
month = oct,
doi = {10.3389/fimmu.2026.2000898},
url = {https://www.frontiersin.org/articles/10.3389/fimmu.2026.2000898/full},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - The mucosal immune microenvironment in chronic pharyngitis: epithelial barrier dysfunction, inflammatory persistence, and therapeutic perspectives
AU - Yao Sun
AU - Zetong Hong
AU - Yiming Guo
AU - Haizhen Cui
AU - Yueyao Jiang
AU - Qian Yu
PY - 2026
DA - 2026/10/23
JO - Frontiers in Immunology
DO - 10.3389/fimmu.2026.2000898
UR - https://www.frontiersin.org/articles/10.3389/fimmu.2026.2000898/full
AB - Chronic pharyngitis is a clinically heterogeneous condition in which persistent throat symptoms, visible mucosal abnormalities, and underlying biological processes do not necessarily coincide. This critical narrative review synthesizes evidence from human chronic pharyngitis, experimental injury models, adjacent upper-airway disorders, and other mucosal systems to examine how epithelial barrier function, innate and adaptive immunity, microbial ecology, sensory signaling, and tissue repair may contribute to disease persistence. Experimental studies identify epithelial injury and activation of shared inflammatory and stress-response pathways, while human observations highlight substantial variation in anatomical site, microbial findings, immune organization, and treatment response. Adaptive immune responses appear strongly context dependent; microbial community changes are most informative when linked to organism viability, metabolite production, host sensing, or colonization resistance; and sensory pathways may contribute to symptoms partly independently of measurable inflammation. We propose that persistent disease can arise through three overlapping routes: continued exposure, durable alteration of tissue responsiveness, and incomplete resolution or repair, with microbial and sensory processes acting as modifiers. This framework separates symptom improvement, biological target engagement, and durable restoration of tissue function as distinct therapeutic outcomes. Future studies should prioritize anatomically precise longitudinal cohorts, site-resolved single-cell and spatial profiling, functional perturbation in primary pharyngeal systems, and mechanism-informed trials with follow-up after treatment withdrawal. By linking clinical presentation to local biological function and recovery trajectories, chronic pharyngitis may be reclassified into reproducible biological subgroups that support more precise mechanistic investigation and treatment.
SN - 1664-3224
ER -